Published Date: 26 Apr 2023
Parkinson's disease is a prevalent neurodegenerative condition that impairs movement. A person's gait and balance are eventually affected by the disease, which frequently starts with minor hand tremors.
Read Full NewsAbout one third of cancers detected by PSA screening at age 70, and more than half at age 80, are unlikely to become clinically meaningful within 15 years.
A ‘target trial’ emulation study suggests that regular exercise can help breast cancer survivors live longer.
Broader implementation would require substantial investment, but long-term dividends of liquid biopsy analysis in the region could affect diagnosis and care of much more than just this cancer.
Counterintuitive findings hint that diets rich in fruit, vegetables, and whole grains may increase the risk of lung cancer in young nonsmokers, but experts are skeptical.
Photopenia in high CT density renal lesions on [18F]FDG PET/CT scans shows a high negative predictive value for excluding malignancy.
A phase 2 study investigates the combination of cladribine plus low-dose cytarabine and venetoclax alternating with azacitidine plus venetoclax for newly diagnosed acute myeloid leukemia.
Approval was based on findings from the phase 3 VERITAC-2 trial showing significantly improved PFS for patients with ESR1-mutated disease.
1.
When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?
2.
No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says
3.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
4.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
5.
HER3 Antibody Drug Conjugate Shows Promise in NSCLC
1.
The Latest Advances in Glioblastoma Treatment and Prevention
2.
The benefits of using magnesium sulfate during pregnancy
3.
The Pros and Cons of Using Cyclophosphamide in Cancer Treatment
4.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
5.
Exploring the Hope of New Treatments for Rhabdomyosarcoma
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
4.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation